Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Formalising Question Management Groups: A Critical Constituent of High-Quality Undergraduate Assessment. [PDF]
Maraj H, Jawaid I.
europepmc +1 more source
The Role of Supply Chain Management in Healthcare Waste Management: A Scoping Review on Reverse Logistics, Inventory Control, and Environmental Health Impacts. [PDF]
Nkomo S +4 more
europepmc +1 more source
Analysis of Quality Normative Requirements: Contributions to the Alignment and Standardization of Standards Applied in Health Laboratories. [PDF]
Fernandez SLC +5 more
europepmc +1 more source
Antimicrobial Stewardship, Laboratory Surveillance, and Quality Management in Africa: A Narrative Review of Challenges and Opportunities for Integrated AMR Control. [PDF]
Owoicho AW, Edward M.
europepmc +1 more source
Artificial Intelligence-Driven Precision Bisphosphonate Therapy in Osteoporosis: Mechanisms, Clinical Applications, Risks, and Future Directions. [PDF]
Yao X +7 more
europepmc +1 more source

